Clinical Trial

A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer

Name: A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer — clinical trial record (NCT07540533)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: 2025-370

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of toripalimab in combination with investigator-selected chemotherapy in patients with recurrent or metastatic HER2-negative breast cancer who have failed prior systemic therapy.

Trial Details

NCT Number	NCT07540533
Lead Sponsor	Henan Cancer Hospital
Conditions	Advanced Breast Cancer
Enrollment	92 participants
Start Date	2026-01-20
Primary Completion	2027-08 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-04-20